Cargando…

Anti‐SARS‐CoV‐2 mRNA vaccines as inducers of humoral response against apolipoprotein A‐1?

BACKGROUND: COVID‐19 and some anti‐SARS‐CoV‐2 vaccines trigger a humoral autoimmune response against a broad range of endogenous components, which may affect recipients’ prognosis in predisposed individuals. Autoantibodies directed against apolipoprotein A‐1 (AAA1 IgG) the major protein fraction of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vuilleumier, Nicolas, Pagano, Sabrina, Ludewig, Burkhard, Schmiedeberg, Kristin, Haller, Christoph, von Kempis, Johannes, Rubbert‐Roth, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286055/ https://www.ncbi.nlm.nih.gov/pubmed/34841527 http://dx.doi.org/10.1111/eci.13713

Ejemplares similares

Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
por: Rubbert-Roth, Andrea, et al.
Publicado: (2021)

Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
por: Schmiedeberg, Kristin, et al.
Publicado: (2022)

Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA
por: Schmiedeberg, Kristin, et al.
Publicado: (2022)

Pausing drugs and spacing vaccines: an open question – Authors' reply
por: Rubbert-Roth, Andrea, et al.
Publicado: (2021)

Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis
por: Haller, Christoph, et al.
Publicado: (2021)

SARS‐CoV‐2 infection as a trigger of humoral response against apolipoprotein A‐1
por: Pagano, Sabrina, et al.
Publicado: (2021)

Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases
por: Raptis, Catherine E., et al.
Publicado: (2022)

SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1
por: Pagano, S., et al.
Publicado: (2021)

Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases
por: Lamacchia, Celine, et al.
Publicado: (2023)

Auto-antibodies against apolipoprotein A-1 block cancer cells proliferation and induce apoptosis
por: Satta, Nathalie, et al.
Publicado: (2020)

Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
por: Bridge, Simon H., et al.
Publicado: (2018)

Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence
por: L'Huillier, A.G., et al.
Publicado: (2022)

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
por: Bitzenhofer, Michaela, et al.
Publicado: (2022)

Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases
por: Teixeira, Priscila Camillo, et al.
Publicado: (2014)

Intra-population differences of apolipoproteins in the aqueous humor
por: Patel, Parth A., et al.
Publicado: (2021)

Anti-Apolipoprotein A-1 IgG Levels Predict Coronary Artery Calcification in Obese but Otherwise Healthy Individuals
por: Quercioli, Alessandra, et al.
Publicado: (2012)

Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients
por: Anderson, Josephine L.C., et al.
Publicado: (2019)

Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy Subjects
por: Vuilleumier, Nicolas, et al.
Publicado: (2019)

Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts
por: Mueller, Ruediger B., et al.
Publicado: (2019)

Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma
por: Farrera-Soler, Lluc, et al.
Publicado: (2020)

Humoral responses to SARS-CoV-2 mRNA vaccines: Role of past infection
por: Gray, Ashley N., et al.
Publicado: (2021)

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?
por: Pagano, Sabrina, et al.
Publicado: (2015)

Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study
por: Pagano, Sabrina, et al.
Publicado: (2023)

Humoral response after a third and fourth dose of mRNA-based SARS-CoV-2 vaccine in previously seronegative kidney transplant recipients
por: Brandstetter, Clara, et al.
Publicado: (2022)

Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
por: Mairhofer, Mario, et al.
Publicado: (2021)

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
por: Strengert, Monika, et al.
Publicado: (2021)

Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
por: Oyaert, Matthijs, et al.
Publicado: (2022)

Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients
por: Kwiatkowska, Ewa, et al.
Publicado: (2022)

Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination
por: Nziza, Nadège, et al.
Publicado: (2023)

Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
por: Marchitto, Lorie, et al.
Publicado: (2023)

Impact of hypertension on long-term humoral and cellular response to SARS-CoV-2 infection
por: Chu, Chang, et al.
Publicado: (2022)

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population
por: Vuilleumier, Nicolas, et al.
Publicado: (2020)

Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms
por: Antiochos, Panagiotis, et al.
Publicado: (2017)

Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022)

Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence
por: L’Huillier, Arnaud G., et al.
Publicado: (2022)

Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab
por: Capuano, Rocco, et al.
Publicado: (2021)

Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients
por: Chumsri, Saranya, et al.
Publicado: (2021)

Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer
por: Figueiredo, Jane C., et al.
Publicado: (2021)

Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Jiménez, Moraima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ts10dlnn4ubske9qhstlvku7g8